Conditions: Androgen Receptor Positive; Locally Advanced Salivary Gland Carcinoma; Metastatic Salivary Gland Carcinoma; Salivary Duct Carcinoma; Salivary Gland Adenocarcinoma, NOS; Salivary Gland Basal Cell Adenocarcinoma; Stage III Major Salivary Gland Cancer AJCC v7
Interventions: Drug: enzalutamide
Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI); Astellas Pharma US, Inc.
Active, not **RECRUITING NOW**
Interventions: Drug: enzalutamide
Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI); Astellas Pharma US, Inc.
Active, not **RECRUITING NOW**
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
